ArticleCancer management and research2020

Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma.

Suying Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.